VHL and cancer: Since lots of cancer-related signaling transduction pathways showed significantly amplified in cancer cells, we then examined the copy number variations in their upstream RTK genes (Robinson et al., 2000; Secrier et al., 2016) to investigate possible reasons for the negative results that tumor did not appear known driver mutations in VHL and PBRM1.